Nyamkhishig Sambuughin
Overview
Explore the profile of Nyamkhishig Sambuughin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
991
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Estevao I, Kazman J, Bramer L, Nicora C, Ren M, Sambuughin N, et al.
Lipids Health Dis
. 2024 Nov;
23(1):380.
PMID: 39548465
Background: The year of 2023 displayed the highest average global temperatures since it has been recorded-the duration and severity of extreme heat are projected to increase. Rising global temperatures represent...
2.
Sambuughin N, Mungunsukh O, Klein M, Ren M, Bedocs P, Kazman J, et al.
Int J Mol Sci
. 2024 Oct;
25(20).
PMID: 39457051
Environmental heat stress represents a pervasive threat to warfighters, athletes, and occupational workers, impacting performance and increasing the risk of injury. Exertional heat illness (EHI) is a spectrum of clinical...
3.
Estevao I, Kazman J, Bramer L, Nicora C, Ren M, Sambuughin N, et al.
Res Sq
. 2024 Jul;
PMID: 38978592
The year of 2023 displayed the highest average global temperatures since it has been recorded-the duration and severity of extreme heat are projected to increase. Rising global temperatures represent a...
4.
Ren M, Sambuughin N, Mungunshukh O, Edgeworth D, Hupalo D, Zhang X, et al.
Genes (Basel)
. 2024 Apr;
15(4).
PMID: 38674343
Sickle cell trait (SCT), although generally a benign carrier state of hemoglobin S (HbAS), is a risk factor for exertional rhabdomyolysis (ERM), a rare but potentially fatal consequence of highly...
5.
Rittenhouse M, Sambuughin N, Deuster P
Nutrients
. 2022 Jul;
14(14).
PMID: 35889922
Methods: This interventional study had a pre- and post-intervention design to assess changes in O3I. Ninety participants completed demographic, biometrics, O3I, and genetic testing. Participants were provided a personalized dose...
6.
Johnston J, Dirksen R, Girard T, Hopkins P, Kraeva N, Ognoon M, et al.
Hum Mol Genet
. 2022 Jul;
31(23):4087-4093.
PMID: 35849058
The ClinGen malignant hyperthermia susceptibility (MHS) variant curation expert panel specified the American College of Medical Genetics and Genomics/Association of Molecular Pathologists (ACMG/AMP) criteria for RYR1-related MHS and a pilot...
7.
Johnston J, Dirksen R, Girard T, Gonsalves S, Hopkins P, Riazi S, et al.
Genet Med
. 2021 Mar;
23(7):1288-1295.
PMID: 33767344
Purpose: As a ClinGen Expert Panel (EP) we set out to adapt the American College of Medical Genetics and Genomics (ACMG)/Association for Molecular Pathology (AMP) pathogenicity criteria for classification of...
8.
Mungunsukh O, Deuster P, Muldoon S, OConnor F, Sambuughin N
Br J Anaesth
. 2019 Jul;
123(3):e461-e463.
PMID: 31301762
No abstract available.
9.
Sambuughin N, Ren M, Capacchione J, Mungunsukh O, Chuang K, Horkayne-Szakaly I, et al.
Case Rep Genet
. 2018 Dec;
2018:6898546.
PMID: 30533233
Individuals with Sickle Cell Trait (SCT), generally considered a benign carrier state of hemoglobin S (HbAS), are thought to be at risk for exertional rhabdomyolysis and hematuria, conditions that can...
10.
Sambuughin N, Smith J, OConnor F, Deuster P
Mol Genet Metab Rep
. 2018 Sep;
17:2.
PMID: 30181954
No abstract available.